A detailed history of Texas Capital Bancshares Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Texas Capital Bancshares Inc holds 1,517 shares of LLY stock, worth $1.22 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
1,517
Previous 1,771 14.34%
Holding current value
$1.22 Million
Previous $1.03 Million 14.34%
% of portfolio
0.54%
Previous 0.55%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $150,418 - $201,239
-254 Reduced 14.34%
1,517 $1.18 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $9,128 - $12,585
21 Added 1.2%
1,771 $951,000
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $42,439 - $56,746
121 Added 7.43%
1,750 $820,000
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $6,523 - $7,661
21 Added 1.31%
1,629 $559,000
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $517,052 - $602,469
1,608 New
1,608 $588,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Texas Capital Bancshares Inc Portfolio

Follow Texas Capital Bancshares Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bancshares Inc with notifications on news.